3-year survival ‘superior’ with TAVI versus surgery in low-risk adults
In low-risk patients, the minimally invasive option led to fewer deaths and disabling strokes
Low-risk patients undergoing transcatheter aortic valve implantation have a 30% lower risk of death or disabling stroke at three years versus those undergoing surgery, US cardiologists report.
Results from their multinational study involving 1400 older adults suggest transcatheter aortic valve implantation (TAVI) with a self-expanding supra-annular valve has “durable” short- and intermediate-term benefits.
